FDA Drug Application (021123) for ULTRACET by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021123
Product Number001
FormTABLET;ORAL
Dosage325MG;37.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameULTRACET
Active IngredientACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient TRAMADOL HYDROCHLORIDE8


Back to FDA Applications sponsored by JANSSEN PHARMS